Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 595 | 1,918 | 0 | 0 | 689 |
| Cost of Goods | 191 | 614 | N/A | N/A | 142 |
| Gross Profit | 404 | 1,304 | N/A | N/A | 547 |
| Operating Expenses | 49,621 | 43,330 | 54,152 | 28,283 | 29,520 |
| Operating Income | -49,026 | -41,412 | -54,152 | -28,283 | -28,831 |
| Interest Expense | 633 | 660 | 245 | 0 | 0 |
| Other Income | 4,376 | 3,141 | 3,095 | -1,863 | 4,170 |
| Pre-tax Income | -45,283 | -38,931 | -51,302 | -30,146 | -24,661 |
| Income Tax | 133 | -2,194 | -772 | 593 | 402 |
| Net Income Continuous | -45,416 | -36,737 | -50,530 | -30,739 | -25,063 |
| Net Income | $-45,416 | $-36,737 | $-50,530 | $-30,739 | $-25,063 |
| EPS Basic Total Ops | -4.60 | -3.80 | -5.60 | -3.50 | 100.50 |
| EPS Basic Continuous Ops | -4.61 | -3.76 | -5.63 | -3.53 | 100.54 |
| EPS Diluted Total Ops | -4.60 | -3.80 | -5.60 | -3.50 | 100.50 |
| EPS Diluted Continuous Ops | -4.61 | -3.76 | -5.63 | -3.53 | 100.54 |
| EBITDA(a) | $-49,615 | $-41,633 | $-55,039 | $-29,442 | $-30,080 |